Showing 141 - 160 results of 395 for search '"Pharmaceutics"', query time: 0.07s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144

    Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection by Mohammed Ali Salih, Dlivan Fattah Aziz, Salar Ibrahim Ali

    Published 2020-06-01
    “…In addition, the calibration curves for diclofenac sodium active pharmaceutical ingredient (API) with linear regressions > 0,999895 obtained linear in the distances 1870-5600 ?…”
    Get full text
    Article
  5. 145
  6. 146
  7. 147

    The effect of maintenance therapy on Crohn’s disease clinical outcomes by O. B. Schukina, E. A. Kondrashina, A. M. Kharitidis, Ye. G. Vepreva, A. G. Kharitonov, A. Yu. Baranovsky

    Published 2018-08-01
    “…Biological therapy should be considered as disease-modifying treatment in patients with inflammatory forms of CD. The decision on pharmaceutical treatment of patients with complications should be made by gastroenterologists in consort with surgeons-coloproctologists.…”
    Get full text
    Article
  8. 148

    Illusory finger stretching and somatosensory responses in participants with chronic hand-based pain. by Kirralise J Hansford, Daniel H Baker, Kirsten J McKenzie, Catherine E J Preston

    Published 2025-01-01
    “…Current pharmaceutical interventions for chronic pain are reported to be minimally effective, leading researchers to investigate non-pharmaceutical avenues for chronic pain treatment. …”
    Get full text
    Article
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155

    Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems. How to prevent side effects related to drug interactions? by S. G. Burkov, N. V. Shornikova

    Published 2011-05-01
    “…As eradication therapy implicates addition to treatment of at least 3 pharmaceuticals of which antibiotics are strictly specified, it is extremely desirable to choose proton pump inhibitor (PPI) with lower affinity to cytochrome Р450. …”
    Get full text
    Article
  16. 156
  17. 157
  18. 158
  19. 159

    The South African guidelines on enuresis: 2024 update by A Adam, A Badenhorst, F Claassen, T de Maayer, M Fockema, J Fredericks, E Gottlich, J John, N Lala, J Lazarus, S Leahy, H N Lourens, S Maharaj, K M Mathabe, E M Moshokoa, S B A Mutambirwa, K L Petersen, M B Radzuma, A van der Merwe, I van Heerden, C A Zietsman, F Alyami, A Deshpande, G H H Smith

    Published 2024-11-01
    “…These options include behavioural modification, urotherapy, pharmaceutical therapy, alarm therapy, alternative therapies, neuromodulation, psychological support and biofeedback. …”
    Get full text
    Article
  20. 160

    Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013) by A. A. Sheptulin, M. A. Vizye-Khripunova

    Published 2014-09-01
    “….), that may progress under a mask of the functional intestinal disorders is required. The range of pharmaceuticals has been replenished by new agents (linaclotide, prucalopride), increasing efficacy of IBS and CFC treatment.Conclusion. …”
    Get full text
    Article